A case of Chromoblastomycosis caused by Fonsecaea monophora in Hainan fisherman

Abstract

Abstract: Here we report a case of chromoblastomycosis caused by Fonsecaea momophora. A 80-year-old man was admitted to the hospital with a more than eleven years’s history of plaque on the right hand. Direct microscopic examination and fungal culture, histopathologic examination, ribosomal internal transcribed spacer (ITS) sequence analysis were performed. The thick-walled, brown sclerotic bodies were observed by direct microscopic examination and histopathological examination. Fungal culture yielded black brown villiform colonies and rhinocladiella type and cladosporium type conidia were observed in the slide culture. The isolate was identified as Fonsecaea momophora according to the ITS sequencing. The patient was prescribled itraconazole(200 mg/d) combined with terbinafine (250 mg/d) for 4 months.The lesions improved greatly and the patient was now under followed-up.

Key words: Fonsecaea monophora, chromoblastomycosis, itraconazole, terbinafine, subcutaneous mycoses

CLC Number:

R756.6

NIU Mu, LIAO Wanqing, WU Weiwei, ZHENG Wenai. A case of Chromoblastomycosis caused by Fonsecaea monophora in Hainan fisherman[J]. Chinese Journal of Mycology, 2021, 16(3): 184-187.

References

[1] Queiroz-Telles F,Esterre P,Perez-Blanco M,et al.Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment[J].Med Mycol,2009,47(1):3-15.
[2] Yap FB.Chromoblastomycosis[J].Int J Infect Dis,2010,14(6):543-544.
[3] Queiroz-Telles F, de Hoog S, Santos DW, et al. Chromoblastomycosis[J]. Clin Microbiol Rev.2017,30(1):233-276.
[4] Brito AC,Bittencourt MJS.Chromoblastomycosis:an etiological,epidemiolog-ical,clinical,diagnostic,and treatment update[J].An Bras Dermato,2018,93(4):495-506.
[5] Deng S, Tsui CK,Gerrits van den Ende AH, et al. Global spread of human chromoblastomycosis is driven by recombinant Cladophialophora carrionii and predominantly clonal Fonsecaea species[J].PLoS Negl Trop Dis,2015,9(10):e0004004.
[6] Queiroz-Telles F,Nucci M,Colombo AL,et al.Mycoses of implantation in Latin America: an overview of epidemiology, clinical manifestations, diagnosis and treatment[J].Med Mycol,2011,49(3):225-236.
[7] Agarwal R,Singh G,Ghosh A,et al.Chromoblastomycosis in India: Review of 169 cases[J].PLoS Negl Trop Dis,2017,11(8):e0005534.
[8] Queiroz-Telles F,de Hoog S,Santos DW,et al.Chromoblastomycosis[J].Clin Microbiol Rev,2017,30(1):233-276.
[9] 孙祺琳,余敏,陈骏,等.中国大陆地区52例皮肤着色芽生菌病回顾性分析[J],中国真菌学杂志,2020,15(2):101-105.
[10] De Hoog GS,Attili-Angelis D,Vicente VA,et al. Molecular ecology and pathogenic potential of Fonsecaea species[J].Med Mycol,2004,42(5):405-416.
[11] Xi L,Sun J,Lu C,et al. Molecular diversity of Fonsecaea(Chaetothyriales) causing chromoblastomycosis in southern China[J].Med Mycol,2009,47(1):27-33.
[12] 周欣,刘玉梅,高爱莉,等. Fonsecaea monophora所致皮肤着色芽生菌病3例病原学鉴定及临床分析[J].中国皮肤性病学杂志,2015,29(8):798-801.
[13] 李东明,李若瑜,王端礼,等.致病性外瓶霉的PCR-RELP分类[J].中华皮肤科杂志,2000,29(1):10-12.
[14] Queiróz AJR, Pereira Domingos F, Antônio JR. Chromoblastomycosis: clinical experience and review of literature[J]. Int J Dermatol, 2018, 57(11): 1351-1355.
[15] Bonifaz A,Paredes-Solís V,Saúl A.Treating chromoblastomycosis with systemic antifungals[J].Expert Opin Pharmacother,2004,5(2):247-254.
[16] Ameen M.Managing chromoblastomycosis[J].Trop Doct,2010,40(2):65-67.
[17] Ameen M.Chromoblastomycosis:clinical presentation and management[J]. Clin Exp Dermatol,2009,34(8):849-854.